Literature DB >> 6257160

New method for large-scale growth; and concentration of the Epstein-Barr viruses.

G P Shibley, M Manousos, K Munch, I Zelljadt, L Fisher, S Mayyasi, K Harewood, R Stevens, K E Jensen.   

Abstract

Efficacious systems are described for the large-scale growth in tissue culture and concentration of infectious (P3HR-1) and transforming (B95-8) Epstein-Barr virus. Also recorded here are our updated procedures for growing stock cultures and protocols to harvest fluids containing biologically active virus which is infectious or transforming. Various methods of concentrating biologically active Epstein-Barr virus have been evaluated. Cellular debris can be removed efficiently and rapidly from culture harvest fluids by clarification through a JCF-Z continuous-flow rotor. Efficient and reliable virus concentration was achieved by molecular filtration with Millipore Pellicon cassettes, using flow rates to 10 liters/h to produce fivefold concentrates followed by pelletization in a fixed-angle rotor. Data from recent production lots showed an average infectivity titer for P3HR-1 virus of 10(4.5) early antigen units per ml (100-fold concentrate) and 10(5.7) transforming units per ml (200-fold concentrate) for B95-9 virus lots.

Entities:  

Mesh:

Year:  1980        PMID: 6257160      PMCID: PMC291719          DOI: 10.1128/aem.40.6.1044-1048.1980

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  22 in total

1.  Concentration of Epstein-Barr virus from cell culture fluids with polyethylene glycol.

Authors:  A Adams
Journal:  J Gen Virol       Date:  1973-09       Impact factor: 3.891

2.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

3.  Stimulation of mammary tumor virus production in a mouse mammary tumor cell line.

Authors:  E Y Lasfargues; B Kramarsky; N H Sarkar; J C Lasfargues; N Pillsbury; D H Moore
Journal:  Cancer Res       Date:  1970-04       Impact factor: 12.701

4.  Adaptation and infection of mouse bone marrow (JLS-V9) cells in suspension culture for production of Rauscher leukemia virus.

Authors:  H M Hodge; F Klein; A K Bandyopadhyay; O R Robinson; G P Shibley
Journal:  Appl Microbiol       Date:  1974-01

5.  In vitro cultivation of the mouse mammary tumor virus: replication of MTV in tissue culture.

Authors:  R D Cardiff; P R Blair; K B DeOme
Journal:  Virology       Date:  1968-10       Impact factor: 3.616

6.  Replication of herpes-type virus in a Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; J T Grace
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

7.  Rapid semiquantitative method for screening large numbers of virus samples by negative staining electron microscopy.

Authors:  J H Monroe; P M Brandt
Journal:  Appl Microbiol       Date:  1970-08

8.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

9.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

10.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

View more
  4 in total

Review 1.  Downstream processing in the biotechnology industry.

Authors:  Manohar Kalyanpur
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

2.  Evaluation of latex-based heterophile antibody assay for diagnosis of acute infectious mononucleosis.

Authors:  L Cook; J Midgett; D Willis; B Clinton; J D Folds
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

Review 3.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

4.  PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.

Authors:  Wen Zheng; Yuhuan Gao; Xiaoyan Ke; Weijing Zhang; Liping Su; Hanyun Ren; Ningjing Lin; Yan Xie; Meifeng Tu; Weiping Liu; Lingyan Ping; Zhitao Ying; Chen Zhang; Lijuan Deng; Xiaopei Wang; Yuqin Song; Jun Zhu
Journal:  BMC Cancer       Date:  2018-09-21       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.